about
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORErythropoietin and diabetes mellitusStem cell guidance through the mechanistic target of rapamycinFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyFoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specificationRegeneration in the nervous system with erythropoietinCharting a course for erythropoietin in traumatic brain injury.Forkhead transcription factors: new considerations for alzheimer's disease and dementia.Mitochondrial dysfunction and oxidative stress in aging and cancer.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.cGMP Signaling Increases Antioxidant Gene Expression by Activating Forkhead Box O3A in the Colon Epithelium.A Central Role for Phosphorylated p38α in Linking Proteasome Inhibition-Induced Apoptosis and Autophagy.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.Disease onset and aging in the world of circular RNAs.MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development?Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.Molecular changes in obese and depressive patients are similar to neurodegenerative disorders.Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia
P2860
Q26749047-74B00B79-B359-41DB-955F-BBCF5FB5CFA6Q26777878-8E15FC84-D5BE-49DB-9EF0-8FD2AE84A955Q26795544-223C549E-EC97-40C9-B1EE-57285F1C2754Q26800615-51950585-E859-44DA-AF31-A1CF98A78FBCQ28066377-C914DCE0-7940-4A50-8CA9-A2591924AE12Q28080095-CE5BC3D1-31CA-4940-802A-674B90A2D09DQ36247651-B8F0D7F9-C24F-4728-B24D-9A71C9D34F59Q36791150-385FDBBC-8356-4DFE-8B91-44DB135B2A0CQ37064987-0A64EF9B-E939-4850-B41A-0B23A4CA3AADQ37564295-91F32FD5-A0A3-4BF9-9B93-45C2476BD18AQ38607849-3D79C06B-1EED-4ED9-B1B6-44CD39CB9C9FQ38655453-11BB3ADE-9F92-4B93-9BB8-1DCB500603F8Q38725204-F1AB555B-5DC8-4F96-846E-9A04D8E3A690Q38731909-59F303D7-C7BC-4906-81D4-725A0809196CQ38789540-156F64CD-E95F-4E20-B8AC-FB78A7D89373Q41082884-A38E900F-0729-42F7-81B6-F1557C721C14Q41109519-9BD421C4-E40C-467F-A81A-3A67E5B53A72Q41902364-02FB40CC-77E1-4260-A066-3D13B8ED35A7Q45305554-3F314C48-0BA4-4B91-B4EB-0C1506341849Q51761339-07B1BC06-BA15-443E-8455-326D90DFA1D2Q52361076-77DBFCB1-DCF5-4010-987B-E7848CA6DCA8Q54089791-6041C29F-FC1C-4D2F-BFAD-4B2A39715C91Q56967214-65C6EF22-FC70-48BF-8FA9-66096BCE0995
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
FoxO proteins in the nervous system.
@en
FoxO proteins in the nervous system.
@nl
type
label
FoxO proteins in the nervous system.
@en
FoxO proteins in the nervous system.
@nl
prefLabel
FoxO proteins in the nervous system.
@en
FoxO proteins in the nervous system.
@nl
P2860
P921
P356
P1433
P1476
FoxO proteins in the nervous system.
@en
P2093
Kenneth Maiese
P2860
P304
P356
10.1155/2015/569392
P577
2015-06-10T00:00:00Z